CLINICAL_TRIALS
trial_result
· 2015-06-26
Clinical Trial Update: Low Dose Naltrexone for Glioma Patients [Phase 2]
Summary
Phase 2 study evaluating low-dose naltrexone in malignant glioma has completed and results are posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Katy Peters | Conditions: Malignant Glioma | Phase 2 | Status: COMPLETED | Results posted: 2015-06-26